Yazar "Durmuş, Hacer" için listeleme
-
CD4(+) T cells of myasthenia gravis patients are characterized by ıncreased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS
Çebi, Merve; Durmuş, Hacer; Aysal, Fikret; Özkan, Berker; Engin Gül, Gizem; Çakar, Arman; Hocaoğlu, Mehmet; Mercan, Metin; Yentur, Sibel Penbe; Tütüncü, Melih; Yayla, Vildan; Akan, Onur; Doğan, Öner; Parman, Yeşim; Saruhan-Direskeneli, Güher (Frontiers Media SA, 2020)Myasthenia gravis (MG) is an autoimmune disease mediated by autoantibodies predominantly against the acetylcholine receptor (AChR). Specific T cell subsets are required for long-term antibody responses, and cytokines ... -
A database for screening and registering late onset Pompe disease in Turkey
Çelik Gökyiğit, Münevver; Ekmekçi, Hakan; Durmuş, Hacer; Karlı, Necdet; Köseoğlu, Emel; Aysal, Fikret; Kotan, Dilcan; Ali, Asuman; Kahraman Koytak, Pınar; Karasoy, Hatice; Yaman, Aylin; Şengün, İhsan Şükrü; Sayın, Refah; Tiftikcioğlu, Bedile Irem; Soysal, Aysun; Tutkavul, Kemal; Oytun Bayrak, Ayşe; Kısabay, Ayşın; Elçi, Mehmet Ali; Yayla, Vildan; Yılmaz, İbrahim Arda; Özdamar, Sevim Erdem; Erdoğan, Çağdaş; Taşdemir, Nebahat; Oflazer, Zehra Piraye (Pergamon-Elsevier Science Ltd, 2018)The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patients who had a myopathy with unknown diagnosis registered in the pre-diagnostic part of a novel registry for LOPD within a ... -
Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)
Çebi, Merve; Durmuş, Hacer; Yılmaz, Vuslat; Yentür, Sibel Penbe; Aysal, Fikret; Oflazer, Zehra Piraye; Parman, Yeşim Gülşen; Deymeer, Feza; Saruhan-Direskeneli, Güher (Wiley, 2019)A small subset of myasthenia gravis (MG) patients develop autoantibodies against muscle-specific kinase (MuSK), which are predominantly of the immunoglobulin (Ig)G4 isotype. MuSK-MG is strongly associated with HLA-DRB1*14, ... -
Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database
Tunca, Ceren; Şeker, Tuncay; Akçimen, Fulya; Coşkun, Cemre; Bayraktar, Elif; Palvadeau, Robin; Zor, Seyit; Koçoğlu, Cemile; Kartal, Ece; Şen, Nesli Ece; Hamzeiy, Hamid; Özoğuz Erimiş, Aslıhan; Norman, Utku; Karakahya, Oğuzhan; Olgun, Gülden; Akgün, Tahsin; Durmuş, Hacer; Şahin, Erdi; Çakar, Arman; Başar Gürsoy, Esra; Babacan Yıldız, Gülşen; İşak, Barış; Uluç, Kayıhan; Hanağası, Haşmet; Bilgiç, Başar; Turgut, Nilda; Aysal, Fikret; Ertaş, Mustafa; Boz, Cavit; Kotan, Dilcan; İdrisoğlu, Halil; Soysal, Aysun; Uzun Adatepe, Nurten; Akalın, Mehmet Ali; Koç, Filiz; Tan, Ersin; Oflazer, Piraye; Deymeer, Feza; Taştan, Öznur; Çiçek, Ercüment; Kavak, Ersen; Parman, Yeşim; Başak, Nazlı (Wiley, 2020)The last decade has proven that amyotrophic lateral sclerosis (ALS) is clinically and genetically heterogeneous, and that the genetic component in sporadic cases might be stronger than expected. This study investigates ...